cDNA-PCR Sequencing Kits for long-read sequencing.
ID: 75N95025Q00008-RFQType: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of cDNA-PCR Sequencing Kits for long-read sequencing, as part of a combined synopsis/solicitation. The primary objective is to acquire Promethion Flow Cell packs and sequencing kits to support high-throughput sequencing efforts aimed at advancing research on neurodegenerative diseases, particularly Alzheimer's disease. This procurement is crucial for the Center for Alzheimer’s Disease and Related Dementias (CARD) and is expected to facilitate the identification of causative genes and potential therapeutic targets. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on December 30, 2024, referencing Solicitation Number 75N95025Q00008, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines a Request for Proposal (RFP) for the procurement of supplies, specifically cDNA-PCR long read sequencing kits and PromethION Flow Cells, intended for the Center for Alzheimer’s Disease and Related Dementias (CARD). The primary objective is to facilitate neurodegenerative disease research via high-throughput cDNA-PCR sequencing, contributing to the identification of causative genes and potential therapeutic targets for Alzheimer’s disease and related dementias. The supplies will be integral to CARD’s research efforts, which are part of a collaborative initiative by the NIH. Key requirements include consumables that are compatible with Oxford Nanopore's PromethION devices, capable of generating up to 290 Gb for sequencing and allowing the pooling of multiple libraries. The document specifies the quantities needed—25 packs of Flow Cells and 34 sequencing kits, with options for additional supplies over the subsequent years. It also details delivery requirements to NIH’s National Institute on Aging in Baltimore, along with anticipated delivery timelines spanning from August 2025 to August 2027. Overall, the RFP emphasizes the government’s commitment to advancing Alzheimer's research through necessary technological support.
    The document outlines the "Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment," specifying regulations related to the procurement of covered telecommunications equipment as mandated by the John S. McCain National Defense Authorization Act for Fiscal Year 2019. It establishes that offerors are prohibited from providing, using, or entering into contracts involving such equipment if it constitutes a significant component of any system or critical technology. Offerors must complete specific representations concerning their use or provision of covered telecommunications services or equipment and provide detailed disclosures if applicable. The document emphasizes due diligence requirements for offerors to check the System for Award Management (SAM) for excluded parties and accurately represent their telecommunications equipment or services to ensure compliance with federal regulations, thus safeguarding national security interests. Overall, this provision serves as a mechanism to ensure that federal contracts do not involve potentially harmful telecommunications technologies.
    The document outlines the provisions related to the representation concerning "covered telecommunications equipment or services" as part of federal contracts. It defines these terms referencing clause 52.204-25 and mandates that offerors conduct due diligence by checking the System for Award Management (SAM) for excluded parties associated with such equipment. In a structured format, the offeror must certify whether they provide or utilize covered telecommunications equipment or services in their offerings to the government. This includes a self-representation regarding the presence or absence of such equipment in their contracts, supported by a reasonable inquiry. The certification requires the authorized individual from the offeror’s organization to sign, confirming the provided information. This provision is critical in ensuring that federal contracts do not involve telecommunications equipment that may pose security risks, reinforcing the government’s commitment to maintaining integrity and security in its procurement processes.
    The document outlines a series of Federal Acquisition Regulation (FAR) clauses relevant to contracts involving commercial products and services. The main purpose is to ensure compliance with various laws and Executive Orders, particularly those affecting ethics, subcontracting, and small business utilization. Key provisions include regulations on whistleblower protections, restrictions on contracts with certain entities, and guidelines for small business participation in federal contracting. Specific clauses mandate reporting of executive compensation, establish requirements for labor standards, and outline prohibitions related to products from designated foreign entities. Importantly, the document includes labor laws aimed at protecting worker rights, such as the Fair Labor Standards Act and Service Contract Labor Standards. The structure consists of numbered clauses, designating which provisions apply to contracts based on their nature and funding sources. The comprehensive list of clauses indicates the federal government's intent to maintain rigorous standards in contracting while enhancing opportunities for small businesses. This document serves a critical role in guiding contractors and ensuring accountability and transparency in government procurement processes.
    The Trade Agreements Certificate is a provision included in federal solicitations to ensure compliance with trade agreements. It requires the offeror to certify that all end products, except those listed as "other end products," are either U.S.-made or from designated countries. Offerors must specify any products that do not meet these criteria, including their country of origin. The government evaluates offers based on the Federal Acquisition Regulation (FAR), particularly part 25, which governs trade agreements. For products covered under the World Trade Organization Government Procurement Agreement (WTO GPA), U.S.-made or designated products are prioritized, although exceptions can be made by the Contracting Officer if offers are inadequate. This provision aims to encourage the use of domestic products, aligning with government policies on procurement while also adhering to international trade agreements.
    The Information and Communication Technology (ICT) Accessibility Notice outlines requirements for offerors responding to solicitations, mandating compliance with established HHS ICT accessibility standards under Section 508. Offerors must submit either a HHS Section 508 Accessibility Conformance Checklist or an Accessibility Conformance Report (ACR) to demonstrate conformity with these standards. The document details the responsibilities of contractors regarding remediation of any non-compliant supplies or services identified after contract award. Additionally, electronic content delivered must be accessible per HHS criteria, with specific checklists available for various formats. The emphasis is on ensuring that all ICT supplies and documentation conform to accessibility standards, facilitating HHS's assessment of compliance. This notice is part of the federal government's effort to promote inclusivity through accessible technology in federal grants and RFPs, establishing a framework for accountability regarding accessibility in ICT supplied to government entities.
    The document outlines the requirements for compliance with Section 508 of the Rehabilitation Act concerning information and communication technology (ICT) in contracts. Effective February 2024, all ICT supplies, products, platforms, information, documentation, and services developed or delivered under federal contracts must adhere to Revised 508 Standards. Contractors must ensure that these ICT solutions conform to accessibility guidelines and are responsible for remedying any non-compliance at their own cost. For contract modifications adding new ICT items, contractors must provide a Section 508 Accessibility Conformance Checklist or an Accessibility Conformance Report to confirm adherence to standards. In the case of indefinite delivery contracts, detailed specifications regarding accessibility will be provided in task orders, with similar documentation requirements. Notably, contractors are obliged to inform Contracting Officers of any perceived exemptions to Section 508 standards. This clause emphasizes the federal government’s commitment to ensuring accessibility in ICT products and services, fostering inclusivity in governmental operations and support.
    The document outlines the invoice and payment provisions for contractors engaged with the federal government, particularly in the context of Purchase Orders, Task Orders, and Blanket Purchase Agreements. It emphasizes the requirements for submitting proper invoices, detailing essential components such as vendor information, unique identifiers, and descriptions of supplied goods or services. Contractors are instructed to use the Department of Treasury’s Invoice Processing Platform (IPP) for electronic submissions. Invoice payments are to be made within 30 days following receipt of a proper invoice or government acceptance, with provisions for prompt payment on certain perishable goods. Interest penalties apply for late payments, governed by the Prompt Payment Act. Additionally, it mandates accelerated payments to small business subcontractors within 15 days of receipt by the contractor, emphasizing support for small enterprises. The document also stipulates that all payment requests should be submitted electronically, with guidance on alternate procedures if necessary. This comprehensive structure aims to facilitate timely and accurate financial interactions between the government and its contractors, ensuring compliance with federal regulations and promoting efficiency in the procurement process.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Long Sequencing Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIDA, is seeking qualified small businesses to provide Long Sequencing Kits as part of a Sources Sought notice. The primary objective of this procurement is to acquire kits that facilitate long read sequencing for analyzing biomarkers related to Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD), which are crucial for understanding disease progression and therapeutic efficacy. The kits must meet specific technical requirements, including compatibility with Nanopore PromethION 48 sequencers and the ability to generate substantial sequencing data in real-time. Interested parties must submit their capability statements to Andrea Clay at amcgee@nida.nih.gov by December 31, 2024, at 12:00 PM Eastern Time, as this notice is strictly for research and information purposes and does not obligate the government to award a contract.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    Genotyping Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for genotyping services to analyze 1,500 DNA samples related to Alzheimer's Disease and Related Dementias research. The selected contractor will perform microarray genotyping using Illumina Infinium Global Diversity + Neurobooster Arrays, ensuring quality control and timely reporting of results to support the National Institute on Aging's objectives in advancing research in this critical area. Proposals must be submitted electronically by 11:00 A.M. Eastern on December 27, 2024, to Hashim Dasti at hashim.dasti@nih.gov, with the anticipated award being a firm fixed-price purchase order for a period of twelve months after receipt of order. Interested parties should ensure compliance with all applicable federal regulations and provide evidence of their capability to fulfill the requirements outlined in the solicitation.
    Single-plex NULISApcr Absolute Quantification Assay of HDGFL2 in Plasma Samples
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the development of a single-plex NULISApcr absolute quantification assay to measure HDGFL2 levels in plasma samples, linked to TDP-43 dysfunction associated with Alzheimer’s Disease and Related Dementias (ADRD). The project aims to establish a biomarker for HDGFL2, which is crucial for advancing research and treatment in neurological disorders. The anticipated contract will be a firm fixed-price purchase order with a performance period of twelve months, and proposals must be submitted electronically to Emily Palombo at emily.palombo@nih.gov by 9:00 a.m. Eastern Daylight Time on December 23, 2024. Interested parties should ensure compliance with all relevant FAR provisions and include necessary certifications in their submissions.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    J--NICHD: Service: PacBio Sequel II Service Agreement
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a sole source contract to Pacific Biosciences of California for a PacBio Sequel II Service Agreement. This procurement is essential for maintaining two advanced PacBio sequencers that are critical for NICHD researchers, ensuring their reliable operation while minimizing downtime and repair costs. The contract will cover one year of service, including preventive maintenance, software updates, remote diagnostics, and the provision of necessary reagents, with a performance period from January 11, 2025, to January 10, 2026, and the possibility of three option years. Interested parties are encouraged to submit their interest and capabilities by December 27, 2024, to determine if a competitive procurement process will be initiated. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or +1 301 480 6914.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    NOTICE OF INTENT FOR iSEQ 100 ADVANCE, Mi SEQ, AND NEXT SEQ 2000 SILVER SUPPORT PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Illumina for a Silver Support Plan covering specific laboratory equipment, including the Nextseq 2000 and MiSeq systems. This support plan includes comprehensive services such as full coverage for parts, labor, and travel, OEM parts and service, reagent replacement due to equipment failures, scheduled maintenance visits, remote technical support, and timely on-site response, all over a 12-month term billed quarterly. The procurement is critical for maintaining the operational efficiency of NIAID's laboratory capabilities, ensuring that essential equipment remains functional and supported. Interested vendors must submit their responses via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 23, 2024, at 10:00 AM EST, and should direct any inquiries to Leah Hinson at leah.hinson@nih.gov.
    Opera Phenix Plus High-Content Screening System (or equal)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an Opera Phenix Plus High-Content Screening System or an equivalent product for the Intramural Center for Alzheimer’s and Related Dementias (CARD). The procurement aims to acquire a high-content imaging system capable of analyzing cellular samples, including organoids and tissue slices, to support research on neurodegenerative diseases. This initiative is critical for advancing the understanding of Alzheimer’s disease and related conditions through the analysis of induced pluripotent stem cells (iPSCs). Interested vendors must submit their capability statements by December 27, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring compliance with the specified requirements and guidelines.
    The Role of Mitochondrial Genetic Variation in Dementia
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small business sources for a project titled "The Role of Mitochondrial Genetic Variation in Dementia." The objective of this procurement is to obtain laboratory analysis of mitochondrial genetic variation in brain tissue samples from dementia patients, which will aid in understanding the relationship between mitochondrial function and Alzheimer's disease. This initiative is crucial as it aims to explore potential pathways to dementia through the examination of mitochondrial DNA mutations and oxidative capacity in patient samples. Interested contractors must submit their responses by January 2, 2025, to Kevin Alvarez at kevin.alvarez@nih.gov, detailing their capabilities and business size status, as this opportunity is particularly focused on small businesses.